| Affordable Dentures - Bluff City, P.c. | |
|
4516 Highway 11 E Bluff City TN 37618-2553 | |
| (423) 538-5197 | |
| Not Available |
| Full Name | Affordable Dentures - Bluff City, P.c. |
|---|---|
| Speciality | Dentist |
| Location | 4516 Highway 11 E, Bluff City, Tennessee |
| Authorized Official Name and Position | Terry L Brown (DMD/PRACTICE OWNER) |
| Authorized Official Contact | 4235385197 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Affordable Dentures - Bluff City, P.c. 4516 Highway 11 E Bluff City TN 37618-2553 Ph: () - | Affordable Dentures - Bluff City, P.c. 4516 Highway 11 E Bluff City TN 37618-2553 Ph: (423) 538-5197 |
| NPI Number | 1730547217 |
|---|---|
| Provider Enumeration Date | 01/29/2016 |
| Last Update Date | 01/29/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730547217 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DS0000009827 (Tennessee) | Primary |
News Archive
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
U.S. Renal Care, Inc. (USRC), a leading privately-held provider of outpatient dialysis services, today announced it has started construction of a dialysis center in Grove, Oklahoma, the company's first in the state. The center, expected to open in December 2010, will bring the company's patient total to more than 5,500 served across 85 dialysis centers, home and specialty hospital dialysis programs and facilities. The expansion into northeast Oklahoma is part of USRC's commitment to serving rural communities without dialysis or nephrology services.
Small sensory devices could help to improve walking recovery during stroke rehabilitation in a bid to reduce social isolation.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
Roll Call: Senate Republicans have stepped-up their message attack against President Barack Obama's latest push to pass health reform. "A key element of the Senate GOP's plan appears to be to try to scare House Democrats against voting for the health care plan, arguing that there's no guarantee that the Senate approves a reconciliation package."
› Verified 2 days ago